These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36388081)

  • 1. Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects.
    Yang L; Shen Q; Hu C; Wang Y; Zhu X; Shu S; Luo Z
    Drug Des Devel Ther; 2022; 16():3865-3876. PubMed ID: 36388081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Fluconazole on the Pharmacokinetic Properties of Imrecoxib, a Novel NSAID: A Single-center, Open-label, Self-controlled Study in Healthy Chinese Male Volunteers.
    Zuo CZ; Gong Y; Hou XY; Zhang YF; Peng WX; Zhu RH; Zhong DF; Chen XY
    Clin Ther; 2018 Aug; 40(8):1347-1356. PubMed ID: 30017171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of imrecoxib in patients with renal insufficiency.
    Pei Q; Xie JL; Huang J; Liu WY; Yang XY; Wang Y; Li W; Tan HY; Zhang H; Yang GP
    Eur J Clin Pharmacol; 2019 Oct; 75(10):1355-1360. PubMed ID: 31243478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Liu Y; Zhang R; Li Z; Zhou J; Yang T; Yang C; Huang X; Zhang Y; Shi S
    Sci Rep; 2019 Oct; 9(1):15774. PubMed ID: 31673051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose investigation of imrecoxib in patients with renal insufficiency based on modelling and simulation.
    Li Y; Wang J; Huang J; Yu J; Wang Y; Tan H; Zhang H; Yang G; Pei Q
    Eur J Pharm Sci; 2020 Sep; 152():105449. PubMed ID: 32621967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
    Chen XH; Bai JY; Shen F; Bai AP; Guo ZR; Cheng GF
    Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imrecoxib: Advances in Pharmacology and Therapeutics.
    Wang YH; Zhu LL; Li TL; Zhou Q
    Drug Des Devel Ther; 2024; 18():1711-1725. PubMed ID: 38799798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and excretion of imrecoxib in rat.
    Xu H; Zhang Y; Sun Y; Zhang P; Chu F; Guo Z; Zhang H; Zhong D
    Xenobiotica; 2006 May; 36(5):441-55. PubMed ID: 16854781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of imrecoxib and its two active metabolites in plasma of hepatic impairment patients by liquid chromatography-tandem mass spectrometry.
    Hou X; Dai X; Yang Y; Zhang Y; Zhong D; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1122-1123():58-63. PubMed ID: 31153132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate.
    Hou X; Zhou J; Yu S; Zhou L; Zhang Y; Zhong D; Chen X
    Drug Metab Dispos; 2018 Sep; 46(9):1320-1328. PubMed ID: 29980580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
    Choi Y; Han H; Shin D; Lim KS; Yu KS
    Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age and sex on the pharmacokinetics and safety of avibactam in healthy volunteers.
    Tarral A; Merdjan H
    Clin Ther; 2015 Apr; 37(4):877-86. PubMed ID: 25769615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects.
    Osterloh IH; Muirhead GJ; Sultana S; Whaley S; van den Berg F; Atiee G
    J Sex Med; 2018 Nov; 15(11):1547-1557. PubMed ID: 30341006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.
    Feng Z; Chu F; Guo Z; Sun P
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2270-2. PubMed ID: 19286379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
    Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
    Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
    Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
    Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical trial of HC-1119 soft capsule in Chinese healthy adult male subjects: Pharmacokinetics and safety of single-dose proportionality and effects of food.
    Ma H; Xu W; Ni J; Zhao N; Tang S; Li S; Cai T; Xiu J; Kang X; Gao S; Zhang L; Zhou T
    Prostate; 2022 Feb; 82(2):276-285. PubMed ID: 34807458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and Safety of Enzalutamide in Healthy Chinese Male Volunteers.
    Liu YM; Wu P; Fukushi R; Yamada S; Chen Q
    Clin Ther; 2019 Feb; 41(2):261-268. PubMed ID: 30642613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.